Oral contraceptives and hypertension.
Open Access
- 1 March 1988
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 11 (3_pt_2) , II11-5
- https://doi.org/10.1161/01.hyp.11.3_pt_2.ii11
Abstract
Oral contraceptives result in a mild elevation of blood pressure in most women and overt hypertension in about 5%. Both estrogen and progestogen are responsible for the blood pressure effect, but the mechanism is as yet unknown. The risk of cardiovascular complications is found primarily in women over 35 years of age and in those who smoke. Preparations with an estrogen content of 30 g and a progestogen content of 1 mg or less appear to be safe.Keywords
This publication has 21 references indexed in Scilit:
- Red-Cell Lithium-Sodium Countertransport and Renal Lithium Clearance in HypertensionNew England Journal of Medicine, 1986
- THE RENIN–ANGIOTENSIN SYSTEM AND TOTAL BODY SODIUM AND POTASSIUM IN HYPERTENSIVE WOMEN TAKING OESTROGEN–PROGESTAGEN ORAL CONTRACEPTIVESClinical Endocrinology, 1983
- Blood pressure and contraceptive useBMJ, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- FURTHER ANALYSES OF MORTALITY IN ORAL CONTRACEPTIVE USERS *1Royal College of General Practitioners' Oral Contraception StudyThe Lancet, 1981
- Role of angiotensin II in oral contraceptive hypertension in anesthetized ratsLife Sciences, 1980
- ŒSTROGEN CONTENT OF ORAL CONTRACEPTIVESThe Lancet, 1977
- Effect of chronic administration of an oral contraceptive on the blood pressure of ratsToxicology and Applied Pharmacology, 1973
- Oral contraceptives and hypertension. An epidemiological survey.Heart, 1972
- ORAL CONTRACEPTIVES AND HYPERTENSIONThe Lancet, 1967